Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market
Rhea-AI Summary
Medical Care Technologies (OTC PINK:MDCE) has announced the development of a patent-pending AI Mental Health Tracker, targeting the $400 billion global mental health market. The innovative platform utilizes advanced technologies including high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to detect psychological distress markers.
The technology is designed to operate through smartphones and webcams, offering accessible mental health diagnostics worldwide. MDCE plans to integrate this tracker into its multi-vertical health platform, with a beta app launch scheduled for 2026. The solution aims to serve various sectors including telehealth, education, military, and workplace wellness programs.
Positive
- Targeting large addressable market worth $400 billion
- Patent-pending technology leveraging advanced AI capabilities
- Non-invasive, scalable solution accessible through common devices
- Multiple potential revenue streams across telehealth, education, military, and workplace sectors
Negative
- Product still in development with beta launch not until 2026
- Faces regulatory and approval uncertainties
- Operating in highly competitive digital health market
News Market Reaction – MDCE
In the Sep 2 session, MDCE gained 50.00%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MESA, ARIZONA / ACCESS Newswire / September 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an innovator in AI-powered healthcare technologies, today announced its AI Mental Health Tracker, a breakthrough solution designed to transform how anxiety, depression, and PTSD are detected and monitored. Visit the official site for more details at https://medicalcaretechnologies.com.
The. patent pending proprietary platform will leverage high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to uncover subclinical signs of psychological distress often missed by traditional screenings. With the ability to operate seamlessly through smartphones and webcams, this tool provides scalable, cost-effective access to real-time mental health diagnostics worldwide.
The global mental health market is valued at more than
"Mental health remains one of the most underserved areas in global healthcare," said Marshall Perkins III. "Our AI solution has the potential to revolutionize early detection, improve access, and dramatically reduce risk."
MDCE plans to integrate the AI Mental Health Tracker into its multi-vertical health platform, with a beta app launch targeted for 2026.
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire